Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03049111 · ClinicalTrials.gov registry record · Early Phase 1
Screening Inhaled Allergen Challenge for Dermatophagoides Farinae
A Early Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 14
- Enrollment target
NCT03049111 is a Early Phase 1 study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 14 participants.
The verdict
NCT03049111, a Early Phase 1 study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study is designed to identify Dermatophagoides farinae, or Der f, sensitive asthmatics who demonstrate a late phase asthmatic response after Der f inhalation. These subjects may be invited to participate in a planned future study investigating novel asthma treatments.
Interventions
- BIOLOGICAL Der f
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-01-29 |
| Est. Completion | 2019-10-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03049111
The ClinicalTrials.gov registry entry for NCT03049111 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Der f is the first listed.
NCT03049111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03049111 about?
NCT03049111 is a clinical study titled "Screening Inhaled Allergen Challenge for Dermatophagoides Farinae". This study is designed to identify Dermatophagoides farinae, or Der f, sensitive asthmatics who demonstrate a late phase asthmatic response after Der f inhalation. These subjects may be invited to participate in a planned future study investigating novel asthma treatments.
What is the current status of trial NCT03049111?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 14 participants. The study started on 2018-01-29. Estimated completion is 2019-10-03.
What interventions are being tested in trial NCT03049111?
The interventions under investigation include: Der f (BIOLOGICAL).
Who is sponsoring clinical trial NCT03049111?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.